<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Tracking therapeutic cells using k-edge imaging in a murine stroke model Experiment number: MD1011</title>
				<funder ref="#_zVY76qv">
					<orgName type="full">ESRF</orgName>
				</funder>
				<funder ref="#_DQVVUGx">
					<orgName type="full">European Synchrotron Radiation Facility</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Herwig</forename><surname>Requardt</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Marlene</forename><surname>Wiart</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Carmen</forename><forename type="middle">Elisa</forename><surname>Cuccione</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Carmen</forename><forename type="middle">Rahima</forename><surname>Sbaa</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Hélène ELLAUME*</orgName>
								<orgName type="institution" key="instit2">INSERM</orgName>
								<orgName type="institution" key="instit3">UGA EA</orgName>
								<address>
									<addrLine>7442 Emmanuel BRUN*</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">INSERM</orgName>
								<orgName type="institution" key="instit2">UGA EA</orgName>
								<address>
									<postCode>7442</postCode>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">Solveig REYMOND*</orgName>
								<orgName type="institution" key="instit2">INSERM</orgName>
								<orgName type="institution" key="instit3">UGA EA</orgName>
								<address>
									<postCode>7442</postCode>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Tracking therapeutic cells using k-edge imaging in a murine stroke model Experiment number: MD1011</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">40923C3B2E798172B704C98E731DE486</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-24T00:24+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction:</head><p>Stroke is one of the most common causes of death in the western world. The administration of therapeutic cells directly into the brain infarct cavity at the chronic stage of ischemic stroke is able to promote brain regeneration and to rescue motor function. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref> However, one of the limitation of the intracerebral delivery of cells is substantial cell death. To overcome this problem, therapeutic cells can be embedded and delivered in a protective hydrogel. <ref type="bibr" target="#b2">3</ref> A common requirement for the development of regenerative therapies for ischemic stroke is a non-invasive mean to visualize both cells biodistribution and hydrogel following their delivery. Our purpouse is to develop selective bi-color imaging of the regenerative medicine therapy, i.e. specific imaging of therapeutic cells on the one hand and of the cell-embedding hydrogel on the other. We plan to investigate two innovative strategies: K-edge imaging using spectral photon-counting CT (SPCCT) <ref type="bibr" target="#b3">4</ref> and Kedge imaging using synchrotron radiation. K-edge imaging with Synchrotron-produced x-rays (SXR) will serve us as a gold standard for validation of the recently developped SPCCT approach (project supported by a H2020 grant in which we are partners, <ref type="url" target="http://www.spcct.eu/">http://www.spcct.eu/</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials &amp; Methods:</head><p>For our experiment, different bio-compatible metal-based nanoparticles were considered as contrast agents: gold-nanoparticles (AuNPs, Pr Cormode, University of Pennsylvania) for therapeutic cells labeling, and gadolinium-nanoparticles (GdNPs, Pr Parola, ENS, France) or iodine-nanoparticles (INPs, Pr Chevalier, LAGEP, France) for hydrogel labeling. We prepared phantoms for a range of concentrations of these nanoparticles to test for techniques sensitivity and obtain calibration curves for quantification analysis. Phantoms containing a combination of contrast agents were also prepared. Cells were labelled in vitro with the AuNPs and then intracerebrally (IC) delivered a hydrogel labelled with GdNPs (n=3) or INPs (n=3) in a rat model of neuroinflammation. Animals were in vivo imaged by SPCCT the day after injection and 5 to 6 days after, and then in vivo imaged by SXR betweend 9 to 10 days post-injection. To perform K-edge imaging of a given element, an absorption image is first acquired just below the binding energy of the K shell electrons (Au: 79.7 keV; Gd: 49.2 keV; I: 32.2 keV) and then just above the binding energy of the electrons of the element of interest (Au: 81.7 keV; Gd: 51.2 keV; I: 34.2 keV). <ref type="bibr" target="#b4">5</ref> The subtraction of these two acquisitions produces a specific image of the element. The imaging set-up at ID17 consisted of the fixed exit monochromator coupled with the PCO-edge camera (21 μm spatial resolution).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results:</head><p>Our results show that specifc in vivo k-edge imaging of multiple elements was feasible using the ID17 imaging set up, providing proof of concept of bi-color k-edge imaging by SPCCT and SXR for intracerebrally delivered gold-labelled cells embedded within gadolinium-labelled or iodine-labelled hydrogel. In the Figure , 
SPCCT and SXR images for gold-labelled cells embedded in an iodine-labelled hydrogel are shown. The analysis of the regions of interest (volume and contrast agents concentration) for the different imaging techniques are ongoing, and will be compared to the contrast agents quantification on tissue brains samples by mass spectrometry (ICP-MS).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure. Proof of concept of in vivo specific bi-color imaging with SPCCT and SXR.</head><p>Rats with a brain lesion are injected with a neuro-regenerative "repair kit" composed of therapeutic cells embedded within a hydrogel. For this rat, cells were labelled with gold, and hydrogel with iodine. SPCCT imaging is shown on the left: conventional attenutation image, and material-specific images (k-edge reconstruction for Au and material decomposition for I). On the right, SXR imaging: images acquired just above the k-edge energy of Au and I, and corresponding materialspecific images (substraction between the images acquired just above the k-edge energy and those acquired just below the k-edge energy, for each material). HU: Hounsfield Unit; Au: gold; I: iodine; MRI: magnetic resonance imaging, SPCCT: single photon counting computed tomography; SXR: synchrotron-produced x-rays.</p><p>Conclusions &amp; Perspectives: These results provide a reference for the validation of k-edge imaging with SPCCT, a new technology with high potential for in vivo molecular imaging with CT. In vivo K-edge imaging of multiple elements was successfully performed with synchrotron radiation. The next step is to confirm these pilot results and to rigorously evaluate and validate our innovative approaches by including more live animals for quantification studies and statistical analysis.</p><p>Aknowledgements:</p></div><figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="2,45.50,278.50,505.75,282.35" type="bitmap" /></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div><p>This work was performed within the frame of the <rs type="grantNumber">H2020</rs> <rs type="projectName">SPCCT</rs> project (<ref type="url" target="http://www.spcct.eu/">http://www.spcct.eu/</ref>) and was supported by the <rs type="funder">European Synchrotron Radiation Facility</rs> (<rs type="funder">ESRF</rs>, project <rs type="grantNumber">MD1011</rs>) by allocation of beamtime.</p></div>
			</div>
			<listOrg type="funding">
				<org type="funded-project" xml:id="_DQVVUGx">
					<idno type="grant-number">H2020</idno>
					<orgName type="project" subtype="full">SPCCT</orgName>
				</org>
				<org type="funding" xml:id="_zVY76qv">
					<idno type="grant-number">MD1011</idno>
				</org>
			</listOrg>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">&lt;i&gt;Correction to:&lt;/i&gt; Weng Z, et al. Stem Cells Dev 2014 Jul 15;23:1704–1716</title>
		<author>
			<persName><forename type="first">L</forename><surname>Chen</surname></persName>
		</author>
		<idno type="DOI">10.1089/scd.2013.0509.correx</idno>
	</analytic>
	<monogr>
		<title level="j">Stem Cells and Development</title>
		<title level="j" type="abbrev">Stem Cells and Development</title>
		<idno type="ISSN">1547-3287</idno>
		<idno type="ISSNe">1557-8534</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="882" to="882" />
			<date type="published" when="2016-06">2016. 2016</date>
			<publisher>Mary Ann Liebert Inc</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Chen L et al. Stem Cells Int. 2016, 1-8 (2016).</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke</title>
		<author>
			<persName><forename type="first">Quynh</forename><surname>Vu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Kate</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mark</forename><surname>Eckert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Weian</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Steven</forename><forename type="middle">C</forename><surname>Cramer</surname></persName>
		</author>
		<idno type="DOI">10.1212/wnl.0000000000000278</idno>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<title level="j" type="abbrev">Neurology</title>
		<idno type="ISSN">0028-3878</idno>
		<idno type="ISSNe">1526-632X</idno>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="1277" to="1286" />
			<date type="published" when="2014-04-08">2014</date>
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Vu Q et al. Neurology 82, 1277-86 (2014).</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Biomaterial Applications in Cell‐Based Therapy in Experimental Stroke</title>
		<author>
			<persName><forename type="first">Ligia</forename><forename type="middle">S B</forename><surname>Boisserand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Tomonobu</forename><surname>Kodama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jérémie</forename><surname>Papassin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rachel</forename><surname>Auzely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Anaïck</forename><surname>Moisan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Claire</forename><surname>Rome</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Olivier</forename><surname>Detante</surname></persName>
		</author>
		<idno type="DOI">10.1155/2016/6810562</idno>
	</analytic>
	<monogr>
		<title level="j">Stem Cells International</title>
		<title level="j" type="abbrev">Stem Cells International</title>
		<idno type="ISSN">1687-966X</idno>
		<idno type="ISSNe">1687-9678</idno>
		<imprint>
			<biblScope unit="volume">2016</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">6810562</biblScope>
			<date type="published" when="2016-01">2016. 2016</date>
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Boisserand LSB et al. Stem Cells Int. 2016, 6810562 (2016).</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Spectral CT: a technology primer for contrast agent development</title>
		<author>
			<persName><forename type="first">Carsten</forename><forename type="middle">O</forename><surname>Schirra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bernhard</forename><surname>Brendel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mark</forename><forename type="middle">A</forename><surname>Anastasio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ewald</forename><surname>Roessl</surname></persName>
		</author>
		<idno type="DOI">10.1002/cmmi.1573</idno>
	</analytic>
	<monogr>
		<title level="j">Contrast Media &amp; Molecular Imaging</title>
		<title level="j" type="abbrev">Contrast Media &amp; Molecular</title>
		<idno type="ISSN">1555-4309</idno>
		<idno type="ISSNe">1555-4317</idno>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="62" to="70" />
			<date type="published" when="2014-01">2014</date>
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Schirra CO et al. Contrast Media Mol. Imaging 9, 62-70 (2014).</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><surname>Elleaume</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell. Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1065" to="1075" />
			<date type="published" when="2000">2000</date>
			<pubPlace>Noisy-le-grand</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Elleaume H et al. Cell. Mol. Biol. (Noisy-le-grand). 46, 1065-75 (2000).</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
